Literature DB >> 10514007

Cross-antagonism of a T cell clone expressing two distinct T cell receptors.

B N Dittel1, I Stefanova, R N Germain, C A Janeway.   

Abstract

Inhibition of T cell activation can be mediated by analogs of the original antigenic peptide (TCR antagonists). Here, a T cell clone expressing two distinct TCR was used to investigate whether such inhibition involves an active mechanism by examining whether an antagonist for one TCR could influence responses stimulated by the other TCR engaging its agonist. Our results demonstrate functional cross-inhibition under these conditions involving the ability of antagonist: TCR interactions to diminish Lck enzymatic activity associated with the agonist-recognizing second TCR, apparently through enhancement of SHP-1 association with these receptors. Our findings reveal that inhibition of cellular responses by antagonists arises at least in part from active negative regulation of proximal TCR signaling and identify elements of the biochemical process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514007     DOI: 10.1016/s1074-7613(00)80104-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  38 in total

Review 1.  ITAMs versus ITIMs: striking a balance during cell regulation.

Authors:  Daniel D Billadeau; Paul J Leibson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.

Authors:  Barbara J Vilen; Kathy M Burke; Michelle Sleater; John C Cambier
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

3.  Cooperative enhancement of specificity in a lattice of T cell receptors.

Authors:  C Chan; A J George; J Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

4.  Presentation of antagonist peptides to naive CD4+ T cells abrogates spatial reorganization of class II MHC peptide complexes on the surface of dendritic cells.

Authors:  Bartosz Chmielowski; Rafal Pacholczyk; Piotr Kraj; Pawel Kisielow; Leszek Ignatowicz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-31       Impact factor: 11.205

Review 5.  Ligand-dependent regulation of T cell development and activation.

Authors:  Ronald N Germain
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 6.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  T-cell activation: A queuing theory analysis at low agonist density.

Authors:  J R Wedagedera; N J Burroughs
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

Review 8.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 9.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

10.  A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity.

Authors:  Vincent Lombardi; Philippe Stock; Abinav K Singh; Jerome Kerzerho; Wen Yang; Barbara A Sullivan; Xiangming Li; Takayuki Shiratsuchi; Nathan E Hnatiuk; Amy R Howell; Karl O A Yu; Steven A Porcelli; Moriya Tsuji; Mitchell Kronenberg; S Brian Wilson; Omid Akbari
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.